Riskpilot← Back to searchSign inGet full accessEkeby Apotek AB
ABActiveOrg 5590254479Ekeby Bruk 21 ARetail sale of pharmaceutical products · NACE 4773Est. 20152 employees
Revenue 2024
SEK 10,7M
+4% vs 2023
EBITDA margin
4.1%
+171% vs 2023
Equity ratio
49.2%
Financial strength
Net profit 2024
SEK 248K
+836% vs 2023
| Revenue | SEK 10,7M | +4% |
| EBITDA | SEK 436K | +171% |
| Net profit | SEK 248K | +836% |
| Total assets | SEK 4,9M | +2% |
| Equity | SEK 2,4M | +11% |
| Employees | 2 | — |
Legal name
Ekeby Apotek AB
Org number
5590254479
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
4 september 2015
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget har till föremål för sin verksamhet att bedriva handel med receptbelagda apoteksvaror, receptfria apoteksvaror och handelsvaror som lämpar sig för försäljning och distribution till konsumenter genom apotek samt därmed förenlig verksamhet.
Address
Ekeby Bruk 21 A
Email
soran.yarwaessi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 11 015 | 11 163 | 10 315 | 10 295 | 10 668 |
| Staff expenses | — | — | −1 424 | −1 306 | −951 |
| EBITDA | 744 | 350 | 182 | 161 | 436 |
| Depreciation & amort. | −79 | −62 | −57 | −45 | −47 |
| EBIT | 665 | 288 | 125 | 116 | 389 |
| Net financials | −3 | −11 | −54 | −82 | −76 |
| Profit before tax | 661 | 278 | — | — | — |
| Tax | −143 | −64 | −16 | −8 | −66 |
| Net profit | 518 | 214 | 55 | 26 | 248 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 869 | 5 382 | 4 688 | 4 795 | 4 888 |
| Equity | 2 260 | 2 474 | 2 129 | 2 155 | 2 403 |
| Long-term debt | 0 | 1 375 | 1 275 | 1 175 | 1 075 |
| Short-term debt | 1 609 | 1 533 | 1 284 | 1 464 | 1 410 |
| Total debt | 1 609 | 2 908 | 2 559 | 2 639 | 2 485 |
EBITDA margin
4.1%
This company
15.8%
Market median
-74% vs market
20202024
Equity ratio
49.2%
This company
38.2%
Market median
+29% vs market
20202024
Return on equity
10.3%
This company
18.4%
Market median
+44% vs market
20202024
Net profit margin
2.3%
This company
8.1%
Market median
-72% vs market
20202024
Asset turnover
2.18×
This company
1.12×
Market median
+95% vs market
20202024
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JK Chief Auditor | Chief Auditor | 2022 |
SB Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
SM Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Deputy Board Member | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 99% | 99% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Yarwaessi AB
Ekeby Apotek AB Board members of Ekeby Apotek AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jon Karl Lahiru Nilsson | Chief Auditor | 0 companies |
| Soran Bahjat Khalid | Chief Executive Officer | 0 companies |
| Sara Maria Kristina Andersson | Chief Auditor | 0 companies |
| Evin Ahmad | Chairman | 0 companies |
| Dilan Ahmad | Deputy Board Member | 0 companies |